2010
Scientific papers
O’Brien E, Atkins N, , Stergiou G, Parati G, Asmar R, Imai Y,Wang J, Mengden T, Shennan A on behalf of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol for the Validation of Blood Pressure Measuring Devices in Adults. 2010 Revision. Blood Press Monit 2010;15:23–38
Stergiou G, Karpettas N, Atkins N, O’Brien E. European Society of Hypertension International Protocol for the validation of blood pressure monitors: A critical review of its application and rationale for revision. Blood Press Monit 2010;15:39–48
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895–905
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS on behalf of the ASCOT-BPLA and MRC Trial Investigators Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurology 2010;9:469-480
Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O’Brien E, Staessen JA on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic Value of Reading-to-Reading Blood Pressure Variability over 24 Hours in 8938 Subjects from 11 Populations. Hypertension. 2010;55:1049-1057.
Vangjeli C, Clarke N, Quinn U, Dicker P, Tighe O, Ho C, O’Brien E, Stanton AV. Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure. Circ Cardiovasc Genet 2010; 3:53-9
Thijs L, Richart T, de Leeuw PW, Kuznetsova T, Grodzicki T, Kawecka-Jaszcz K, OʼBrien E, Redón J, Birkenhäger WH, Fagard R, Staessen JA. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. J Hypertens. 2010;28:865-74.
Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, Zambanini A, O’Brien E, Chaturvedi N, Lyons S, Byrd S, Poulter NR, Sever PS, Mayet J; on behalf of the ASCOT Investigators. Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J. 2010;31:747-752.
Tapp RJ, Sharp AS, Stanton AV, O’Brien E, Chaturvedi N, Poulter NR, Sever PS, Thom SA McG, Hughes AD, Mayet J on behalf of the ASCOT Investigators. Differential Effects of Anti-hypertension Treatment on Left Ventricular Diastolic Function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial ) sub-study. JACC 2010;55:1875-81
McGowan N, Atkins N, O’Brien E, Padfield P. Computerised reporting improves the clinical use of ambulatory blood pressure measurement. Blood Press Monit 2010.15:115–123
O’Brien E. Ambulatory blood pressure monitoring: 24-hour blood pressure control as a therapeutic goal for improving cardiovascular prognosis. Medicographia 2010;32:241-249
Parati g, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O’Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G on behalf of ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension Practice Guidelines for home blood pressure monitoring. J Hum Hypertens. 2010 Jun 3. [Epub ahead of print]
Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, OʼBrien E, Wang J, Staessen JA; on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from10 populations. J Hypertens 2010, 28:2036–2045
Kikuya M, Staessen JA, Ohkubo T, Thijs L, Asayama K, Satoh M, Hashimoto T, Hirose T, Metoki H, Obara T, Inoue R, Li Y, Dolan E, Hoshi H, Totsune K, Satoh H, Wang J, O’Brien E, Imai Y. How many measurements are needed to provide reliable information in terms of the ambulatory arterial stiffness index? the Ohasama study. Hypertens Res 2010; 1–5 advance online publication, 2 December 2010; doi:10.1038/hr.2010.240
Parati G, Ochan Kilama M, Faini A, Facelli E, Ochen K, Opira C, Mendis S, Wang J, Atkins N, O’Brien E. A new solar powered blood pressure measuring device for low resource settings. Hypertension 2010;56;1047-1053
Waeber B, Mourad JJ, O’Brien E. Nighttime blood pressure: a target for therapy? Curr Hypertens Rep 2010;12:474-9.
Participating investigator
Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, Metoki H, Ohkubo T, Torp Pedersen C, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Sandoya E, Kawecka-Jaszcz K, Ibsen H, Imai Y, Wang J, Staessen JA on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic Value of the Morning Blood Pressure Surge in 5645 Subjects From 8 Populations. Hypertension 2010; 55:1040 – 1048.
Editorials
O’Brien E, White W. Thomas G. Pickering: friend, colleague and scientist. Blood Press Monit 2010, 15:67–69
Dolan E, O’Brien E. Blood Pressure Variability: Clarity for Clinical Practice. Hypertension 2010;56:179-181
O’Brien E, Stergiou G. Who will bell the cat? A call for a new approach for validating blood pressure measuring devices. J Hypertens 2010,28:2378–2381
Letters
O’Brien E. An endothelin antagonist for resistant hypertension. Lancet.2010;375:635-637
Staessen JA, O’Brien E. Clinical thresholds for ambulatory blood pressure measurement reinvented? Rapid response to Head GA, Milhailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010. on-line 30 April 2010. 340: c1104.
Dolan E, O’Brien E. Response to Increased Intervisit Blood Pressure Variability and β Blockade: Measurement imprecision Related to Bradycardia? Hypertension 2010 published online Sep 13, 2010
General and Educational
O’Brien E. Clinical developments in hypertension management. Irish Medical Times. 26.03.2010. p.vii
O’Brien E. Too many guidelines. Cardiology Supplement. Irish Medical News 28.01.2010. p.40
Stergiou G, Karpettas N, Atkins N, O’Brien E.ESH-IP for the validation of blood-pressure monitors; a success story and its future. International Hospital Equipment. 2010;7:6-7.
O’Brien E. Blood pressure variability: clarity for clinical practice. Irish Medical Times 30.04.2010. p.54
O’Brien E. For how long will we live? Irish Medical Times 02.07.2010.p.54
O’Brien E. The vital facts that influence mortality rates. The Irish Times. 13.07.2010.
O’Brien E. Second opinion. The Irish Times. 16.11.2010.
O’Brien E. Technology can help us to reduce the incidence of high blood pressure. Health Matters 2010.p.79-81.
2011
Scientific papers
Boggia J, Thijs L, Hansen TW, Li Y, Kikuya M, Bjorklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, T Kuznetsova, Olszanecka A, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Maestre G, Sandoya E, Kawecka-Jaszcz E, Imai Y, Wang J, Ibsen H, O’Brien E, Staessen JA, on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Ambulatory Blood Pressure Monitoring in 9357 Subjects From 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women. Hypertension. 2011;57:397-405.
Jin Y, Thijs L, Richart T, Li Y, Dolan ed, Wang J-G, Protogerou A, O’Brien E, Staessen JA, Safar M on behalf of the REASON Investigators. Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Research 2011;34:489-495..
Stergiou GS, Karpettas N, Atkins N, O’Brien E. Impact of applying the more stringent validation criteria of the revised European Society of Hypertension International Protocol 2010 on earlier validation studies. Blood Press Monit 2011;16:67–73
O’Brien E. 24-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation . J Int Med 2011; 269:478–495.
Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, Obara T, Inoue R, Li Y, Dolan E, Hoshi H, Hashimoto J, Totsune K, Satoh H, Wang J-G, O’Brien E, Imai Y. How many measurements are needed to provide reliable information in terms of the ambulatory arterial stiffness index? The Ohasama study. Hypertens Res 2011;34:314-8.
O’Brien E. The value of 24-hour blood pressure monitoring to assess the efficacy of antihypertensive drug treatment. Hot Topics in Hypertension 2011;4:7-23
O’Brien E. What to do when faced with an unmeasurable ambulatory blood pressure? J Hypertens 2011, 29:451–453
O’Brien E. Why ABPM Should Be Mandatory in All Trials of Blood Pressure–Lowering Drugs. Drug Information J 2011;45:233–239.
Johnson T, Gaunt TR, Newhouse SJ, Padmanabhan S, Tomaszewski M, Kumari M, Morris RM, Tzoulaki J, O’Brien ET, Poulter NR, Sever P et al. Blood Pressure Loci Identified with a Gene-Centric Array. Am J Hum Gen 2011;89:688-700.
O’Brien E. Why ABPM Should Be Mandatory in All Trials of Blood Pressure–Lowering Drugs. J Clin Studies 2011;3:52-55
Participating investigator
Collier DJ, et al on behalf of the ASCOT Investigators. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Pressure Lowering Arm. (ASCOT-BPLA). J Hypertens 2011;29:583–591.
Gupta AK, et al on behalf of the ASCOT investigators. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens 2011;29:2004–2013.
Collier DJ, et alJ on behalf of the ASCOT Investigators. Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm. J Hypertens 2011;29:592–599.
Editorials
O’Brien E, Parati G. Reverting to simplicity: palpating systolic blood pressure. J Hypertens 2011, 29:27–28
O’Brien E, Stergiou GS. Who will bell the cat? A call for a new approach for validating blood pressure measuring devices. J Hypertens 2010, 28:2378–2381.
Letters
O’Brien E. ABPM part of FDA reviews. Drug Information J 2011;45:567-568.
General and Educational
O’Brien E. A Century of Service: The City of Dublin Skin and Cancer Hospital 1911 0 2011. Anniversary Press. Dublin. 2011.Pp. 320
O’Brien E. ABPM saves not only money but also lives. Ir Med Times 2011.10.14;52.
O’Brien E. NICE guideline to revolutionise our views on hypertension. Ir Med Times 2011.08.04;44.
O’Brien E. The pressure is on to measure up 24/7. Irish Times 2011;03.29.
O’Brien E. ROADMAP – fact and fallacy in one paper. Ir Med Times 2011.06.05;44.
O’Brien E. NICE guideline will revolutionise the way we manage hypertension. IPU Review 2011.19-20.
O’Brien E. Blood Pressure Variability: a new target. Journal by Fax 2011
O’Brien E. Average Blood Pressure Vs. Blood Pressure Variability. American Society of Hypertension. ASH Circulation 2011.6
O’Brien E. ABPM in Blood Pressure Trials. Advantages of ABPM in Blood Pressure Lowering Trials. 2011. Applied Clinical Trials. http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/article/articleDetail.jsp?id=746505.
O’Brien E. NICE guideline will revolutionise the way we manage hypertension. Hospital Pharmacy News 2011. IPU Review 2011;July:19-20
O’Brien E. A breakthrough for measuring BP in the developing world. Ir Med Times 2011.01.14;27.
O’Brien E, Parati G, Mendis S. Affordable technology in low resource countries. J Hypertens 2011. In press
